Your session is about to expire
← Back to Search
Diazepam for Postoperative Pain
Phase 4
Waitlist Available
Led By Rachel Pauls, MD
Research Sponsored by TriHealth Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up between 3.5 and 6 hours postoperatively
Awards & highlights
Study Summary
This trial will study whether the use of rectal diazepam suppositories can decrease postoperative pain after major vaginal pelvic organ prolapse surgery.
Eligible Conditions
- Postoperative Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ between 3.5 and 6 hours postoperatively
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~between 3.5 and 6 hours postoperatively
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Vaginal/Rectal pain in Visual Analogue Scale (VAS) score
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Diazepam groupExperimental Treatment1 Intervention
Rectal Diazepam suppository
Group II: Placebo groupPlacebo Group1 Intervention
Placebo suppository
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Diazepam
FDA approved
Find a Location
Who is running the clinical trial?
TriHealth Inc.Lead Sponsor
95 Previous Clinical Trials
50,838 Total Patients Enrolled
2 Trials studying Postoperative Pain
496 Patients Enrolled for Postoperative Pain
Rachel Pauls, MDPrincipal InvestigatorTriHealth - Cincinnati Urogynecology Associates
23 Previous Clinical Trials
25,885 Total Patients Enrolled
2 Trials studying Postoperative Pain
496 Patients Enrolled for Postoperative Pain
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger